Interferon alpha for chronic hepatitis B

To assess the beneficial and harmful effects of standard interferon alpha alone as compared with no treatment or placebo for chronic hepatitis B in patients with HBeAg-positive or HBeAg negative status.

This is a protocol.

Share/Save